Bladder Cancer
The impact of restaging transurethral resection on recurrence and progression free survival in patients with T1 high grade bladder cancer.
January 12, 2023
New prognostic model in patients with advanced urothelial carcinoma treated with second-line immune checkpoint inhibitors.
January 12, 2023
Avelumab and Talazoparib Treatment in Patients with Advanced Urothelial Cancer - Expert Commentary
January 11, 2023
How to Perform Intravesical Chemotherapy after Second TURBT for Non-Muscle-Invasive Bladder Cancer: A Single-Center Experience.
January 11, 2023
Urine Cytology Rarely Escalates Clinical Management in the Surveillance of Non-muscle-Invasive Bladder Cancer.
January 11, 2023
Cohort profile: Bladder Cancer Data Base Sweden (BladderBaSe) 2.0.
January 10, 2023
Surrogate Endpoints as Predictors of Overall Survival in Metastatic Urothelial Cancer: A Trial-level Analysis.
January 10, 2023
Low CD8 T Cell Counts Predict Benefit from Hypoxia-Modifying Therapy in Muscle-Invasive Bladder Cancer.
January 10, 2023
Pathological pelvic lymph node involvement in muscle-invasive bladder patients treated with radical cystectomy: A narrative review.
January 9, 2023
Quality of Life and Symptom Burden in Bladder Cancer Patients Receiving Immunotherapy - Expert Commentary
January 6, 2023
CD8+ T cell-intrinsic IL-6 signaling promotes resistance to anti-PD-L1 immunotherapy.
January 6, 2023
Association Between Body Mass Index and Outcomes in Patients With Urothelial Carcinoma Treated With Pembrolizumab.
January 6, 2023